Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities    
Net loss $ (6,595) $ (39,014)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 445 494
Depreciation 1 1
Fair value change in warrant liabilities 0 33,829
Unrealized loss from short-term investments 84 0
Change in assets and liabilities:    
Prepaid expenses and other assets 219 (159)
Accounts payable (5) 200
Accrued and other liabilities (319) (1,163)
Net cash used in operating activities (6,170) (5,812)
Investing activities    
Net cash used in investing activities 0 0
Financing activities    
Proceeds from issuance of common stock in connection with the at-the-market program 1,208 0
Issuance costs (30) 0
Payments made in connection with short-term loan (323) 0
Exercise of stock options 27 10
Net cash provided by financing activities 882 10
Net decrease in cash and cash equivalents (5,288) (5,802)
Cash and cash equivalents at beginning of period 24,534 16,399
Cash and cash equivalents at end of period 19,246 10,597
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 0 0
Cash paid for interest 5 0
Supplemental non-cash financing transactions:    
Non-cash reclassification of Series A warrant liability to equity 0 61,793
Unpaid issuance and deferred offering costs $ 5 $ 88